Background and goal of study
============================

CDP Choline (CDPC, citicoline) is one of the neuroprotectants used for the clinical and experimental treatment of stroke \[[@B1]\] and brain injury \[[@B2]\]. In the present study the authors examined the effect of citicholine treatment on survival and neurological outcome in patients with brain injury caused by isolated head trauma.

Materials and methods
=====================

The study was approved by the institution ethical comity. Twenty-eight patients after head trauma (23 men) were randomly enrolled to typical treatment + citicholine (1 g IV for 14 days) group or typical treatment + placebo group. Glasgow Coma and Glasgow Outcome Scale (GCS, GOS) were used to monitor patients up to 30 days.

Results and discussions
=======================

Our preliminary report of the citicoline-treated group shows no correlation between GCS in day 7 (GCS 7) and day 14 (GCS 14). This lack of correlation is interpreted as a result of treatment, and significant correlation between GCS 14 and GCS 21 (*r* = 0.82; *P* \< 0.007) is interpreted as an expanded effect of treatment to 21 days. In the citicoline group, GCS 21 is significantly correlated with GOS 30 (*r* = 0.68; *P* \< 0.01) showing the protective effect of the used drug.

  Variable   *n*   Mean       Standard deviation   Median     Minimum   Maximum
  ---------- ----- ---------- -------------------- ---------- --------- ----------
  GCS 0      14    6.00000    1.10940              6.00000    4.00000   8.00000
  GCS 1      13    6.03846    1.19829              6.00000    4.00000   8.00000
  GCS 7      11    7.13636    2.12239              6.00000    4.00000   10.00000
  GCS 14     10    9.35000    2.62520              9.50000    4.00000   13.00000
  GCS 21     9     11.33333   3.67423              13.00000   4.00000   15.00000
  GCS 30     8     12.50000   2.77746              13.50000   8.00000   15.00000
  GOS 30     14    2.42857    1.55486              2.00000    1.00000   5.00000

Conclusions
===========

Our preliminary results suggest that CDPC can be an effective neuroprotective agent in patients with brain injuries following head trauma. Our study has to and will be continued to confirm our data.
